SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study [The Lancet, 15 Dec 2020]

Title:

SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study

 

Authors:

Hossein Poustchi, Maryam Darvishian, Zahra Mohammadi [et al.]

 

Published:

The Lancet, 15 December 2020

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30858-6/fulltext

 

Background (From the Summary):

Rapid increases in cases of COVID-19 were observed in multiple cities in Iran towards the start of the pandemic. However, the true infection rate remains unknown. We aimed to assess the seroprevalence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 18 cities of Iran as an indicator of the infection rate.